Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Sci Rep ; 12(1): 13201, 2022 08 01.
Article in English | MEDLINE | ID: mdl-35915209

ABSTRACT

Scutellaria baicalensis is a well-studied medicinal plant belonging to the Lamiaceae family, prized for the unique 4'-deoxyflavones produced in its roots. In this study, three native species to the Americas, S. lateriflora, S. arenicola, and S. integrifolia were identified by DNA barcoding, and phylogenetic relationships were established with other economically important Lamiaceae members. Furthermore, flavone profiles of native species were explored. 4'-deoxyflavones including baicalein, baicalin, wogonin, wogonoside, chrysin and 4'-hydroxyflavones, scutellarein, scutellarin, and apigenin, were quantified from leaves, stems, and roots. Qualitative, and quantitative differences were identified in their flavone profiles along with characteristic tissue-specific accumulation. 4'-deoxyflavones accumulated in relatively high concentrations in root tissues compared to aerial tissues in all species except S. lateriflora. Baicalin, the most abundant 4'-deoxyflavone detected, was localized in the roots of S. baicalensis and leaves of S. lateriflora, indicating differential accumulation patterns between the species. S. arenicola and S. integrifolia are phylogenetically closely related with similar flavone profiles and distribution patterns. Additionally, the S. arenicola leaf flavone profile was dominated by two major unknown peaks, identified using LC-MS/MS to most likely be luteolin-7-O-glucuronide and 5,7,2'-trihydroxy-6-methoxyflavone 7-O-glucuronide. Collectively, results presented in this study suggest an evolutionary divergence of flavonoid metabolic pathway in the Scutellaria genus of Lamiaceae.


Subject(s)
Flavanones , Flavones , Scutellaria , Chromatography, Liquid , Flavanones/metabolism , Flavones/metabolism , Flavonoids/metabolism , Phylogeny , Plant Roots/metabolism , Scutellaria baicalensis/metabolism , Tandem Mass Spectrometry
2.
Toxins (Basel) ; 14(5)2022 05 13.
Article in English | MEDLINE | ID: mdl-35622585

ABSTRACT

Botanical pesticides have received increasing attention for sustainable control of insect pests. Plants from the genus Tephrosia are known to produce rotenone and deguelin. Rotenone is known to possess insecticidal activities against a wide range of pests, but deguelin's activities remain largely inconclusive. On the other hand, the biosynthesis of rotenone and deguelin may vary in Tephrosia species. This study analyzed the rotenone and deguelin contents in 13 strains across 4 Tephrosia species over 4 growing seasons using HPLC. Our study shows that the species and even the strains within a species vary substantially in the biosynthesis of rotenone and deguelin, and their contents can be affected by the growing season. After identification of the LC50 values of chemical rotenone and deguelin against Aphis gossypii (Glover) and Bemisia tabaci (Gennadius), leaf extracts derived from the 13 strains were used to test their insecticidal activities against the 2 pests. The results showed that the extracts derived from 2 strains of T. vogelii had the highest insecticidal activity, resulting in 100% mortality of A. gossypii and greater than 90% mortality of B. tabaci. The higher mortalities were closely associated with the higher contents of rotenone and deguelin in the two strains, indicating that deguelin also possesses insecticidal activities. This is the first documentation of leaf extracts derived from 13 Tephrosia strains against 2 important pests of A. gossypii and B. tabaci. The strain variation and seasonal influence on the rotenone and deguelin contents call for careful attention in selecting appropriate strains and seasons to produce leaf extracts for the control of insect pests.


Subject(s)
Aphids , Insecticides , Tephrosia , Animals , Insecticides/toxicity , Plant Extracts/pharmacology , Rotenone/analogs & derivatives , Rotenone/chemistry , Rotenone/toxicity , Tephrosia/chemistry
3.
PLoS One ; 17(4): e0259326, 2022.
Article in English | MEDLINE | ID: mdl-35472200

ABSTRACT

Leaves harvested from kratom [Mitragyna speciosa (Korth.)] have a history of use as a traditional ethnobotanical medicine to combat fatigue and improve work productivity in Southeast Asia. In recent years, increased interest in the application and use of kratom has emerged globally, including North America, for its potential application as an alternative source of medicine for pain management and opioid withdrawal syndrome mitigation. Although the chemistry and pharmacology of major kratom alkaloids, mitragynine and 7-hydroxymitragynine, are well documented, foundational information on the impact of plant production environment on growth and kratom alkaloids synthesis is unavailable. To directly address this need, kratom plant growth, leaf chlorophyll content, and alkaloid concentration were evaluated under three lighting conditions: field full sun (FLD-Sun), greenhouse unshaded (GH-Unshaded), and greenhouse shaded (GH-Shaded). Nine kratom alkaloids were quantified using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method. Greenhouse cultivation generally promoted kratom height and width extension by 93-114% and 53-57%, respectively, compared to FLD-Sun. Similarly, total leaf area and leaf number were increased by 118-160% and 54-80% under such conditions. Average leaf size of plants grown under GH-Shaded was 41 and 69% greater than GH-Unshaded and FLD-Sun, respectively; however, no differences were observed between GH-Unshaded and FLD-Sun treatments. At the termination of the study, total leaf chlorophyll a+b content of FLD-Sun was 17-23% less than those grown in the greenhouse. Total leaf dry mass was maximized when cultivated in the greenhouse and was 89-91% greater than in the field. Leaf content of four alkaloids to include speciociliatine, mitraphylline, corynantheidine, and isocorynantheidine were not significantly impacted by lighting conditions, whereas 7-hydroxymitragynine was below the lower limit of quantification across all treatments. However, mitragynine, paynantheine, and corynoxine concentration per leaf dry mass were increased by 40%, 35%, and 111%, respectively, when cultivated under GH-Shaded compared to FLD-Sun. Additionally, total alkaloid yield per plant was maximized and nearly tripled for several alkaloids when plants were cultivated under such conditions. Furthermore, rapid, non-destructive chlorophyll evaluation correlated well (r2 = 0.68) with extracted chlorophyll concentrations. Given these findings, production efforts where low-light conditions can be implemented are likely to maximize plant biomass and total leaf alkaloid production.


Subject(s)
Mitragyna , Secologanin Tryptamine Alkaloids , Substance Withdrawal Syndrome , Chlorophyll A , Chromatography, Liquid , Mitragyna/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Tandem Mass Spectrometry
4.
Drug Discov Today ; 27(5): 1236-1250, 2022 05.
Article in English | MEDLINE | ID: mdl-34971818

ABSTRACT

The use of expedited approval pathways for anticancer drug development, which provide the advantages of high efficiency and cost-effectiveness, has expanded significantly in recent years. During the past decade, a total of 410 new molecular entities have been approved by the US Food and Drug Administration (FDA), with a steady growth of 6.5% in the US. In Europe, 9-75% of approved anticancer drugs were granted at least one expedited approval program. Various expedited pathways have also been implemented worldwide to address underrepresented medical needs rapidly. China has adapted several expedited approval programs, including breakthrough therapy designation, priority review, and conditional approval, to keep up with the growth in pharmaceutical development. It is expected that worldwide standards for drug approval will become more standardized in the next decade.


Subject(s)
Antineoplastic Agents , Neoplasms , Antineoplastic Agents/therapeutic use , Drug Approval , Drug Development , Neoplasms/drug therapy , Orphan Drug Production , United States , United States Food and Drug Administration
5.
Front Plant Sci ; 12: 694153, 2021.
Article in English | MEDLINE | ID: mdl-34408759

ABSTRACT

Cultivation of hemp (Cannabis sativa L.) in tropical and subtropical regions can be challenging if the flowering behavior of a given cultivar is unknown, poorly understood, or not accurately selected for the photoperiod. Identifying cultivars adapted to local environmental conditions is key to optimizing hemp vegetative and flowering performance. We investigated the effects of varying light cycles in regulating extension growth and flowering response of 15 essential oil and 12 fiber/grain hemp cultivars both indoors and outdoors. Plants were subjected to 11 photoperiods in the controlled rooms ranging from 12 to 18 h, and natural day length in the field. The critical photoperiod threshold was identified for seven essential oil cultivars and two fiber/grain cultivars. "Cherry Wine-CC," "PUMA-3," and "PUMA-4" had the shortest critical day length between 13 h 45 min and 14 h. The flowering of essential oil cultivars was generally delayed by 1-2 days when the photoperiod exceeded 13 h compared with 12 h, and flowering was further delayed by 7-8 days when the photoperiod exceeded 14 h. In fiber/grain cultivars, flowering was generally delayed by 1-3 days when the day length exceeded 14 h. Flowering for most essential oil cultivars was delayed by 5-13 days under a 14-h photoperiod compared with 13 h 45 min, suggesting a photoperiod difference as little as 15 min can significantly influence the floral initiation of some essential oil cultivars. Cultivars represented by the same name but acquired from different sources can perform differently under the same environmental conditions, suggesting genetic variation among cultivars with the same name. Average days to flower of fiber/grain cultivars was correlated with reported cultivar origin, with faster flowering occurring among northern cultivars when compared with southern cultivars. Plant height generally increased as the day length increased in essential oil cultivars but was not affected in fiber/grain cultivars. In addition, civil twilight of ~2 µmol·m-2·s-1 was discovered to be biologically effective in regulating hemp flowering. Collectively, we conclude that most of the essential oil cultivars and some southern fiber/grain cultivars tested express suitable photoperiods for tropical and sub-tropical region cultivation.

6.
Front Plant Sci ; 11: 597696, 2020.
Article in English | MEDLINE | ID: mdl-33408731

ABSTRACT

Leaves harvested from the Southeast Asian tree Mitragyna speciosa (kratom) have a history of use as a traditional ethnobotanical source of medicine to combat fatigue, improve work productivity, and to reduce opioid-related withdrawal symptoms. Kratom leaves contain an array of alkaloids thought to be responsible for the bioactivity reported by users. Interest in the consumptive effects of kratom has led to its recent popularity and use in North America, Western Europe, and Australia. Although the chemistry and pharmacology of select kratom alkaloids are understood, studies have not examined the influence of production environment on growth and alkaloidal content. To directly address this need, 68 kratom trees were vegetatively propagated from a single mother stock to reduce genetic variability and subjected to four varying fertilizer application rates. Leaves were analyzed for chlorophyll concentration, biomass, and alkaloidal content to understand the physiological response of the plant. While increasing rates of fertilizer promoted greater plant growth, relationships with alkaloidal content within leaves were highly variable. Fertility rate had little influence on the concentration of mitragynine, paynantheine, speciociliatine, mitraphylline, and corynoxine per leaf dry mass. 7-Hydroxymitragynine was below the lower limit of quantification in all the analyzed leaf samples. Low to medium rates of fertilizer, however, maximized concentrations of speciogynine, corynantheidine, and isocorynantheidine per leaf dry mass, suggesting a promotion of nitrogen allocation for secondary metabolism occurred for these select alkaloids. Strong correlations (r 2 = 0.86) between extracted leaf chlorophyll and rapid, non-destructive chlorophyll evaluation (SPAD) response allowed for development of a reliable linear model that can be used to diagnose nutrient deficiencies and allow for timely adjustment of fertilization programs to more accurately manage kratom cultivation efforts. Results from this study provide a greater understanding of the concentration and synthesis of nine bioactive alkaloids in fresh kratom leaves and provide foundational information for kratom cultivation and production.

7.
Methods Mol Biol ; 1445: 201-13, 2016.
Article in English | MEDLINE | ID: mdl-27436321

ABSTRACT

As nonviral nucleic acid delivery vehicles, lipid nanoparticles (LNPs) have been widely used. Here we describe the synthesis and evaluation of LNPs based on targeted anionic lipid-coated polyplexs for therapeutic delivery of microRNA (miRNA) mimics. These LNPs are particularly suited for therapeutic delivery of oligonucleotide agents to leukemia cells.


Subject(s)
Anions/chemistry , Lipids/chemical synthesis , MicroRNAs/genetics , Cell Line , Gene Transfer Techniques , Humans , Lipids/chemistry , Liposomes , MicroRNAs/chemistry , Nanoparticles
8.
Mol Pharm ; 13(7): 2555-62, 2016 07 05.
Article in English | MEDLINE | ID: mdl-27253378

ABSTRACT

Lipid-albumin nanoparticles (LAN) were synthesized for delivery of RX-0047, an antisense oligonucleotide (ASO) against the hypoxia inducible factor-1 alpha (HIF-1α) to solid tumor. These lipid nanoparticles (LNs) incorporated a human serum albumin-pentaethylenehexamine (HSA-PEHA) conjugate, which is cationic and can form electrostatic complexes with negatively charged oligonucleotides. The delivery efficiency of LAN-RX-0047 was investigated in KB cells and a KB murine xenograft model. When KB cells were treated with LAN-RX-0047, significant HIF-1α downregulation and enhanced cellular uptake were observed compared to LN-RX-0047. LN-RX-0047 and LAN-RX-0047 showed similar cytotoxicity against KB cells with IC50 values of 19.3 ± 3.8 and 20.1 ± 4.2 µM, respectively. LAN-RX-0047 was shown to be taken up by the cells via the macropinocytosis and caveolae-mediated endocytosis pathways while LN-RX-0047 was taken up by cells via caveolae-mediated endocytosis. In the KB xenograft tumor model, LAN-RX-0047 exhibited tumor suppressive activity and significantly reduced intratumoral HIF-1α expression compared to LN-RX-0047. Furthermore, LAN-RX-0047 greatly increased survival time of mice bearing KB-1 xenograft tumors at doses of either 3 mg/kg or 16 mg/kg. These results indicated that LAN-RX-0047 is a highly effective vehicle for therapeutic delivery of antisense agents to tumor.


Subject(s)
Drug Carriers/chemistry , Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Lipids/chemistry , Nanoparticles/chemistry , Oligonucleotides, Antisense/chemistry , Oligonucleotides/chemistry , Oligonucleotides/therapeutic use , Albumins , Animals , Blotting, Western , Cell Line, Tumor , Drug Carriers/administration & dosage , HeLa Cells , Humans , Mice , Mice, Nude , Reverse Transcriptase Polymerase Chain Reaction , Xenograft Model Antitumor Assays
9.
Mol Pharm ; 13(2): 653-62, 2016 Feb 01.
Article in English | MEDLINE | ID: mdl-26741162

ABSTRACT

MicroRNA-21 (miR-21) is an oncomiR that is frequently upregulated in human cancers. AntimiR-21 (AM-21) is an oligonucleotide complementary to miR-21 that is designed to inhibit its gene silencing activities. To facilitate efficient delivery of AM-21, a novel lipid nanoparticle formulation called QTsome, based on a combination of quaternary amine and tertiary amine cationic lipids, with a distinctive pH-responsive profile, was developed. QTsome/AM-21 comprising DODMA/DOTAP/DOPC/CHOL/mPEG-DPPE and AM-21 oligonucleotide exhibited a mean particle diameter of below 150 nm, moderate zeta potential (+13.2 mV), excellent colloidal stability, and high drug loading efficiency (above 80%). In vitro study showed QTsome/AM-21 induced upregulation of miR-21 targets, including PTEN and DDAH1, in A549 cells while increasing their sensitivity toward paclitaxel (PTX). Finally, tumor regression, prolonged survival, and miR-21 target upregulation were demonstrated in an A549 xenograft mouse model. These data suggest that QTsome/AM-21 warrants further evaluation as an anticancer agent.


Subject(s)
Amines/chemistry , Cations/chemistry , Drug Delivery Systems , Lipids/chemistry , Lung Neoplasms/therapy , MicroRNAs/antagonists & inhibitors , Nanoparticles/administration & dosage , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Blotting, Western , Cell Movement/drug effects , Cell Proliferation/drug effects , Combined Modality Therapy , Female , Humans , Immunoenzyme Techniques , Liposomes , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Mice , Mice, Nude , MicroRNAs/genetics , Nanoparticles/chemistry , Paclitaxel/pharmacology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
10.
Mol Pharm ; 12(6): 2010-8, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-25871632

ABSTRACT

CD33-targeted lipid nanoparticles (aCD33LNs) were synthesized for delivery of GTI-2040, an antisense oligonucleotide (ASO) against the R2 subunit of ribonucleotide reductase, to acute myelogenous leukemia (AML). These LNs incorporated a deoxycholate-polyethylenimine (DOC-PEI) conjugate, which has shown significant activity to facilitate oligonucleotide delivery. Anti-CD33 scFv (aCD33) was added as a targeting ligand. The delivery efficiency of this system was investigated both in vitro and in vivo. When cells were treated with aCD33LN/GTI-2040, significant uptake was observed in CD33 positive Kasumi-1 cells. aCD33LNs loaded with GTI-2040 induced significant down-regulation of R2 mRNA and protein levels in AML cells. Moreover, aCD33LN/GTI-2040 showed a 15-fold reduction in the IC50 of antileukemic drug Ara-C in Kasumi-1 cells. In Kasumi-1 xenograft model, aCD33LN/GTI-2040 showed significant R2 downregulation compared to LN/GTI-2040. Furthermore, aCD33LN/GTI-2040 coadministered with Ara-C was shown to be highly effective in tumor growth inhibition and to greatly increase survival time of mice bearing Kasumi-1 xenograft tumors. The conjugate DOC-PEI has shown an ability to include calcein release from lipid nanoparticles, suggesting a potential mechanism contributing to efficient endosome release by DOC-PEI2K. These results indicate that aCD33LNs are a highly effective vehicle for the therapeutic delivery of antisense agents to AML.


Subject(s)
Leukemia, Myeloid, Acute/drug therapy , Lipids/chemistry , Nanoparticles/chemistry , Oligodeoxyribonucleotides/therapeutic use , Oligonucleotides, Antisense/chemistry , Animals , Cell Line, Tumor , Cell Survival/drug effects , Female , Humans , Liposomes/chemistry , Mice , Oligodeoxyribonucleotides/administration & dosage , Xenograft Model Antitumor Assays
11.
Blood ; 122(23): 3778-83, 2013 Nov 28.
Article in English | MEDLINE | ID: mdl-24085765

ABSTRACT

The coexpression of the MLL partial tandem duplication (PTD) and the FLT3 internal tandem duplication (ITD) mutations associate with a poor outcome in cytogenetically normal acute myeloid leukemia (AML). In mice, a double knock-in (dKI) of Mll(PTD/wt) and Flt3(ITD/wt) mutations induces spontaneous AML with an increase in DNA methyltransferases (Dnmt1, 3a, and 3b) and global DNA methylation index, thereby recapitulating its human AML counterpart. We determined that a regulator of Dnmts, miR-29b, is downregulated in bone marrow of dKI AML mice. Bortezomib exerted a dose-dependent increase in miR-29b expression in AML blasts ex vivo, followed by decreased Dnmts, reduced proliferation, and increased apoptosis. In vivo, bortezomib was not active against dKI AML, yet liposomal-encapsulated bortezomib, as a single agent, reversed downregulation of miR-29b in vivo and induced a long-term (90-day) disease-free remission in 80% of dKI AML mice that exhibited high leukemic burden at the start of therapy, yet showed no signs of relapse at autopsy. Taken together, these data support that liposomal bortezomib, as a single agent, eradicates Mll(PTD/wt):Flt3(ITD/wt) AML in mouse and may represent a powerful and potentially curative approach to high-risk human disease.


Subject(s)
Histone-Lysine N-Methyltransferase/genetics , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/therapy , Myeloid-Lymphoid Leukemia Protein/genetics , fms-Like Tyrosine Kinase 3/genetics , Animals , Antineoplastic Agents/administration & dosage , Boronic Acids/administration & dosage , Bortezomib , DNA Methylation , Drug Carriers , Humans , Leukemia, Experimental/genetics , Leukemia, Experimental/metabolism , Leukemia, Experimental/therapy , Leukemia, Myeloid, Acute/metabolism , Liposomes , Mice , Mice, Mutant Strains , MicroRNAs/genetics , MicroRNAs/metabolism , Mutation , Proteasome Inhibitors/administration & dosage , Pyrazines/administration & dosage , RNA, Neoplasm/genetics , RNA, Neoplasm/metabolism , Tandem Repeat Sequences
12.
J Control Release ; 168(3): 251-61, 2013 Jun 28.
Article in English | MEDLINE | ID: mdl-23567045

ABSTRACT

Lactosylated gramicidin-containing lipid nanoparticles (Lac-GLN) were developed for delivery of anti-microRNA-155 (anti-miR-155) to hepatocellular carcinoma (HCC) cells. MiR-155 is an oncomiR frequently elevated in HCC. The Lac-GLN formulation contained N-lactobionyl-dioleoyl phosphatidylethanolamine (Lac-DOPE), a ligand for the asialoglycoprotein receptor (ASGR), and an antibiotic peptide gramicidin A. The nanoparticles exhibited a mean particle diameter of 73 nm, zeta potential of +3.5mV, anti-miR encapsulation efficiency of 88%, and excellent colloidal stability at 4°C. Lac-GLN effectively delivered anti-miR-155 to HCC cells with a 16.1- and 4.1-fold up-regulation of miR-155 targets C/EBPß and FOXP3 genes, respectively, and exhibited significant greater efficiency over Lipofectamine 2000. In mice, intravenous injection of Lac-GLN containing Cy3-anti-miR-155 led to preferential accumulation of the anti-miR-155 in hepatocytes. Intravenous administration of 1.5 mg/kg anti-miR-155 loaded Lac-GLN resulted in up-regulation of C/EBPß and FOXP3 by 6.9- and 2.2-fold, respectively. These results suggest potential application of Lac-GLN as a liver-specific delivery vehicle for anti-miR therapy.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Antibodies/administration & dosage , Drug Carriers/administration & dosage , Gramicidin/administration & dosage , MicroRNAs/immunology , Nanoparticles/administration & dosage , Animals , Anti-Bacterial Agents/chemistry , Antibodies/chemistry , CCAAT-Enhancer-Binding Proteins/genetics , Carbocyanines/administration & dosage , Carbocyanines/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Drug Carriers/chemistry , Fluorescent Dyes/administration & dosage , Fluorescent Dyes/chemistry , Forkhead Transcription Factors/genetics , Gramicidin/chemistry , Hep G2 Cells , Humans , Lactose/chemistry , Lipids/chemistry , Male , Mice , Mice, Inbred C57BL , Nanoparticles/chemistry , Tissue Distribution
13.
Int J Nanomedicine ; 7: 5465-74, 2012.
Article in English | MEDLINE | ID: mdl-23093902

ABSTRACT

BACKGROUND: N-lactosyl-dioleoylphosphatidylethanolamine (Lac-DOPE) was synthesized and evaluated as a liver-specific targeting ligand via asialoglycoprotein receptors for liposomal delivery of doxorubicin. METHODS: Lactosylated liposomes encapsulating calcein (Lac-L-calcein) or doxorubicin (Lac-L-DOX) composed of egg phosphatidylcholine, cholesterol, monomethoxy polyethylene glycol 2000-distearoyl phosphatidylethanolamine, and Lac-DOPE at 50:35:5:10 (mol/mol) were prepared by polycarbonate membrane extrusion and evaluated in human hepatocellular carcinoma HepG2 cells. Cellular uptake of Lac-L-calcein was monitored by confocal microscopy and by flow cytometry. The cytotoxicity of Lac-L-DOX was evaluated by MTT assay. The pharmacokinetic properties of Lac-L-DOX were studied in normal mice, and its biodistribution and antitumor activity were studied in nude mice with HepG2 xenografts. RESULTS: The size of Lac-L-DOX was less than 100 nm and the liposomes demonstrated excellent colloidal stability. In vitro uptake of Lac-L-calcein by HepG2 cells was four times greater than that of non-targeted L-calcein. In the presence of 20 mM lactose, the uptake of Lac-L-calcein was inhibited, suggesting that asialoglycoprotein receptors mediated the observed cellular uptake. Lac-L-DOX exhibited enhanced in vivo cytotoxicity compared with the nontargeted liposomal doxorubicin (L-DOX), and its pharmacokinetic parameters indicate that Lac-L-DOX has a long blood circulation time (t(1/2) 8.73 hours). Tissue distribution and therapeutic efficacy studies in nude mice bearing HepG2 xenografts show that Lac-L-DOX had significantly stronger tumor inhibitory activity compared with L-DOX and free doxorubicin, along with a higher accumulation of drug within the tumor site and greater cellular uptake by tumor cells. CONCLUSION: These data suggest that lactosylated liposomes are promising drug delivery vehicles for hepatocellular carcinoma.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/metabolism , Doxorubicin/administration & dosage , Glycolipids/pharmacokinetics , Liver Neoplasms/drug therapy , Liver Neoplasms/metabolism , Nanocapsules/chemistry , Phospholipid Ethers/pharmacokinetics , Animals , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/chemistry , Cell Line, Tumor , Doxorubicin/chemistry , Female , Glycolipids/chemistry , Hep G2 Cells , Humans , Liposomes/chemistry , Mice , Phospholipid Ethers/chemistry , Treatment Outcome
14.
Mol Biochem Parasitol ; 164(1): 32-44, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19095013

ABSTRACT

Free-living miracidia of Schistosoma mansoni, upon penetration of the their snail intermediate host, undergo dramatic morphological and physiological changes as they transform to the parasitic sporocyst stage. During this transformation process, developing larvae release a diverse array of proteins, herein referred to as larval transformation proteins (LTPs), some of which are postulated to serve a parasite protective function. In the present study, nanoLC-tandem MS analysis was performed on all proteins represented in entire 1-dimensional SDS-PAGE-separated samples in order to gain a more comprehensive picture of the protein constituents associated with miracidium-to-sporocyst transformation and thus, their potential role in influencing establishment of intramolluscan infections. Of 127 proteins with sufficient peptide/sequence information, specific identifications were made for 99, while 28 represented unknown or hypothetical proteins. Nineteen percent of identified proteins possessed signal peptides constituting a cohort of classical secretory proteins, while 22% were identified as putative nonclassically secreted leaderless proteins based on SecretomeP analysis. Proteins comprising these groups consisted mainly of proteases/protease inhibitors, small HSPs, redox/antioxidant enzymes, ion-binding proteins including those with anti-oxidant Fe-binding activities (ferritins, heme-binding protein), and venom allergen-like (VAL) proteins. A polyclonal antibody generated against whole LTPs recognized proteins primarily associated with the cilia, ciliated epidermal plates and intercellular ridges of miracidia and the tegument of fully transformed sporocysts, identifying these structures as sources of a subset of LTPs. Thus lysis of plates and/or leakage during formation of the sporocyst syncytium likely represent significant contributors to the overall LTP makeup, especially identified nonsecretory proteins. However, as plate release/degradation and tegument formation are part of the normal developmental process, all LTPs regardless of tissue origin, would be expected at the parasite-host interface upon infection. This study significantly expands the repertoire of LTPs associated with larval transformation and identifies several, e.g., those involved in stress responses, proteolysis/inhibition, antioxidant and detoxication, and immune modulation, that may play a parasite protective role during this crucial period of transition.


Subject(s)
Helminth Proteins/analysis , Life Cycle Stages/physiology , Proteomics , Schistosoma mansoni/growth & development , Schistosoma mansoni/metabolism , Animals , Helminth Proteins/isolation & purification , Helminth Proteins/metabolism , Immunohistochemistry , Oocysts/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...